These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21383719)

  • 21. [Clinical efficacy of treating infant cytomegalovirus hepatitis with ganciclovir and impact on cytokines].
    Xiong W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1130-2. PubMed ID: 21322282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological perspectives on chronic hepatitis: virus infection, autoimmunity and xenobiotics.
    Mackay IR
    Hepatogastroenterology; 1999; 46(30):3021-33. PubMed ID: 10626155
    [No Abstract]   [Full Text] [Related]  

  • 23. Viral hepatitis in 2011: a major step forward.
    Marcellin P
    Liver Int; 2011 Jan; 31 Suppl 1():1-2. PubMed ID: 21205130
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis. Advances in antiviral therapy for hepatitis.
    Berenguer M; Wright TL
    Lancet; 1998 Dec 19-26; 352 Suppl 4():SIV15. PubMed ID: 9872162
    [No Abstract]   [Full Text] [Related]  

  • 25. [New antiviral agents in chronic viral hepatitis].
    Gómez Cedenilla A; Zapater Hernández P; García Buey L; Abad Santos F; García Monzón C; González Mateos F; Moreno Otero R
    Rev Clin Esp; 1998 Feb; 198(2):104-13. PubMed ID: 9558926
    [No Abstract]   [Full Text] [Related]  

  • 26. [Health economics in hepatology: who should pay? Is expensive treatment in hepatology cost effective?].
    Rossol S
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S231-3. PubMed ID: 16435721
    [No Abstract]   [Full Text] [Related]  

  • 27. Personalized therapy in chronic viral hepatitis.
    Brunetto MR; Colombatto P; Bonino F
    Mol Aspects Med; 2008; 29(1-2):103-11. PubMed ID: 18068759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis].
    Abdurakhmanov DT
    Ter Arkh; 2013; 85(10):94-7. PubMed ID: 24437226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on viral hepatitis: 2008.
    Degertekin B; Lok AS
    Curr Opin Gastroenterol; 2009 May; 25(3):180-5. PubMed ID: 19387254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.
    Lockhart SM; Salvaggio MR; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Oct; 100(10):388-95. PubMed ID: 18085096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection.
    Li SF; Gong MJ; Zhao FR; Shao JJ; Xie YL; Zhang YG; Chang HY
    Cell Physiol Biochem; 2018; 51(5):2377-2396. PubMed ID: 30537741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral hepatitis: impressive advances but still a long way to eradication of the disease.
    Marcellin P; Asselah T
    Liver Int; 2014 Feb; 34 Suppl 1():1-3. PubMed ID: 24373070
    [No Abstract]   [Full Text] [Related]  

  • 33. [Viral hepatitis: clinical interpretation of antigens and antibodies in the serum].
    Páez Rodríguez O; Valdovinos Díaz MA; Wolpert E
    Rev Gastroenterol Mex; 1985; 50(4):277-87. PubMed ID: 2578016
    [No Abstract]   [Full Text] [Related]  

  • 34. Established and emerging therapies for the treatment of viral hepatitis.
    Forton D; Karayiannis P
    Dig Dis; 2006; 24(1-2):160-73. PubMed ID: 16699274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of new therapies using an animal model of hepatitis virus infection].
    Chayama K; Imamura M
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():69-73. PubMed ID: 26845907
    [No Abstract]   [Full Text] [Related]  

  • 36. [Advances in hepatitis--1981].
    Guardia J
    Med Clin (Barc); 1982 Jan; 78(2):67-8. PubMed ID: 7070133
    [No Abstract]   [Full Text] [Related]  

  • 37. [Herpes simplex virus hepatitis; rare in immunocompetent patients].
    Ozokcu L; de Bruijckere LM; Jansen J; van den Berge M
    Ned Tijdschr Geneeskd; 2009; 153():A55. PubMed ID: 19785845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 39. New antiviral agents for viral hepatitis: our cup runneth over but is only half full.
    Dienstag JL
    Gastroenterology; 1999 Sep; 117(3):525. PubMed ID: 10464127
    [No Abstract]   [Full Text] [Related]  

  • 40. [Viral hepatitis through time].
    Aguirre García J
    Rev Gastroenterol Mex; 1995; 60(4 Suppl 2):S12-7. PubMed ID: 8948766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.